SUSPENSIONS

V.MANIMARANLECTURERDEPARTMENT OF PHARMACEUTICSSRM COLLEGE OF PHARMACY

UNIT IV

Definition.

Classification.

Advantages & disadvantages.

Applications.Theoretic consideration of suspensions.

SedimentationBrownian movementElectrokinetic properties

CONTENTS

Formulation of suspensions

Packing of suspensions

Storage requirement & labelling

Evaluation of suspension

Dissolution study of suspensions

Innovation of suspensions

y The term "Disperse System" refers to a system in which one substance (The Dispersed Phase) is distributed, in discrete units, throughout a second substance (thecontinuous Phase ).

y Each phase can exist in solid, liquid, or gaseous state .

y Suspensions are heterogenous system consisting of 2 phases.

DISPERSE SYSTEM

A solid in liquid dispersion in which the particles are of colloidal size.

DISPERSE SYSTEM

DISPERSED MEDIUM DISPERSED PHASE

oAqueous oily liquid oInsoluble solid

Definition

A Pharmaceutical suspension is a coarse dispersion in which internalphase (therapeutically active ingredient)is dispersed uniformly throughout the external phase.

The internal phase consisting of insoluble solid particles having a range of size(0.5 to 5 microns) which is maintained uniformly through out the suspending vehicle with aid of single or combination of suspending agent.

The external phase (suspending medium) is generallyaqueous in some instance, may be an organic or oily liquid for non oral use.

The reasons for the formulation of a pharmaceutical suspension:

-- when the drug is insoluble in the delivery vehicle.

To mask the bitter taste of the drug.

To increase drug stability.

To achieve controlled/sustained drug release.

y 1. Antacid oral suspensions y 2. Antibacterial oral suspension y 3. Dry powders for oral suspension (antibiotic) y 4. Analgesic oral suspension y 5. Anthelmentic oral suspension y 6. Anticonvulsant oral suspension y 7. Antifungal oral suspension

SOME MARKETED SUSPENSIONSSOME PHARMACEUTICAL SUSPENSIONS

Oral suspensioneg: Paracetamol suspensionantacids, Tetracycline HCl.

Externally applied suspensioneg :Calamine lotion.

Parenteral suspensioneg: Procaine penicillin GInsulin Zinc Suspension

ClassificationBased On General Classes

Based on Proportion of Solid Particles

Dilute suspension (2 to10%w/v solid)

Eg: cortisone acetate, predinisolone acetate

Concentrated suspension (50%w/v solid)

Eg: zinc oxide suspension

Based on Electrokinetic Nature of Solid Particles

Flocculated suspension

Deflocculated suspension

Based on Size of Solid Particles

Colloidal suspensions (< 1 micron)

-Suspensions having particle sizes of suspended solid less than about 1micron in size are called as colloidal suspensions.

Coarse suspensions (>1 micron)Suspensions having particle sizes of greater than about 1micron in diameter are called as coarse suspensions.

Suspensions are the biphasic colloidal dispersions of nanosized drug particles stabilized by surfactants. Size of the drug particles is less than 1mm.

Nano suspensions (10 ng)

Coarse dispersionBarium sulphate

Advantages And Disadvantages

.Suspension can improve chemical stability of certain drug.E.g. Procaine penicillin G.

Drug in suspension exhibits higher rate of bioavailability than other dosage forms.

Solution > Suspension > Capsule > Compressed Tablet > Coated tablet

Duration and onset of action can be controlled.E.g. Protamine Zinc-Insulin suspension.

Suspension can mask the unpleasant/ bitter taste of drug.E.g. Chloramphenicol

Advantages

Physical stability , sedimentation and compaction can causes problems.

It is bulky sufficient care must be taken during handling and transport.

It is difficult to formulate.

Uniform and accurate dose can not be achieved unless suspension are packed in unit dosage form.

Disadvantages

Applications

Suspension is usually applicable for drug which is insoluble (or ) poorly soluble.E.g. Prednisolone suspension

To prevent degradation of drug or to improve stability of drug.E.g. Oxy tetracycline suspension

To mask the taste of bitter of unpleasant drug.E.g. Chloramphenicol palmitate suspension

Suspension of drug can be formulated for topical application e.g. Calamine lotion

Suspension can be formulated for parentral application in order to control rate of drug absorption. E.g. penicillin procaine

Vaccines as a immunizing agent are often formulated as suspension.E.g. Cholera vaccine

X-ray contrast agent are also formulated as suspension .eg: Barium sulphate for examination of alimentary tract.

The suspended particles should not settle rapidly and sediment produced, must be easily re-suspended by the use of moderate amount of shaking.

It should be easy to pour yet not watery and no grittiness.

It should have pleasing odour , colour and palatability.

Good syringeability.

It should be physically,chemically and microbiologically stable.

Parenteral /Ophthalmic suspension should be sterilizable.

Features Desired In Pharmaceutical Suspensions

THEORITIC CONSIDERATION OF SUSPENSIONS

A knowledge of the theoretic considerations pertaining to suspension s technology ultimately help formulator to select ingredients that are

Appropriate for suspension preparation

That available for milling

Mixing equipment

Some theoretic considerations are :

Particle size control.

Wetting

Sedimentation

Brownian movement

Electokinetic

Aggregation

Particle size control:- Particle size of any suspension is critical and must be reduced within the range .-Too large or too small particles should be avoided.

Larger particles will: settle faster at the bottom of the container particles > 5 um impart a gritty texture to the productand also cause irritation if injected or instilled to the eye particles > 25 um may block the needle

-Too fine particles will easily form hard cake at the bottomof the container.

Wetting of the particlesy Hydrophilic materials (talc, ZnO, Mg2CO3) are easily

wetted by water while hydrophobic materials (sulphur , charcoal) are not due to the layer of adsorbed air on the surface.

y Thus, the particles, even high density, float on the surface of the liquid until the layer of air is displaced completely.

y The use of wetting agent allows removing this air fromthe surface and to easy penetration of the vehicle into the pores.

y However hydrophobic materials are easily wetted bynon-polar liquids.

THEORY OF SEDIMENTATION

SEDIMENTATION:

Sedimentation means settling of particle (or) floccules occur

under gravitational force in liquid dosage form.

2.1.

Velocity of sedimentation expressed by Stokes equation

Where, d = Diameterof particle

r = radius of particle

vsed.= sedimentation velocity in cm / sec

s= density of disperse phase o= density of disperse media

g = acceleration due to gravity o = viscosity of disperse medium in poise

Limitation Of Stokes Equation .

Stoke's equation applies only to:

Spherical particles in a very dilute suspension (0.5 to 2 gm per 100 ml)

Particles which freely settle without collision .

Particles with no physical or chemical attraction.

Sedimentation Parameters

Sedimentation volume (F) or height (H) for flocculated suspensions:Definition:

Sedimentation volume is a ratio of the ultimate volume of sediment (Vu) to the original volume of sediment (VO)before settling.

F = V u / VO

Where, Vu = final or ultimate volume of sedimentVO = original volume of suspension before settling

F has values ranging from less than one to greater than one.

When F < 1 Vu < Vo

When F =1 Vu = Vo

The system is in flocculated equilibrium and show no clear supernatant on standing.

When F > 1 Vu > VoSediment volume is greater than the original volume dueto the network of flocs formed in the suspension and soloose and fluffy sediment

The sedimentation volume gives only a qualitative account of flocculation.

Fig : Suspensions quantified by sedimentation volume (f)

Degree of flocculation ()It is the ratio of the sedimentation volume of the flocculated suspension ,F , to the sedimentation volume of the deflocculated suspension, F

= F / F

(Vu/Vo) flocculated = --------------------

(Vu/Vo) deflocculated

The minimum value of is 1,when flocculated suspension sedimentation volume is equal to the sedimentation volume of deflocculated suspension.

.2.Brownian Movement (Drunken walk)

Brownian movement of particle prevents sedimentationby keeping the dispersed material in random motion.

Brownian movement depends on the density of dispersedphase and the density and viscosity of the disperse medium.

The kinetic bombardment of the particles by the molecules of the suspending medium will keep the particles suspending, provided that their size is below critical radius (r).

Brownian movement can be observed,

If particle size is about 2 to 5mm,

When the density of particle & viscosity of medium are favorable.

Brownian motion is given by equation:

Where, R = gas constantT = temp. in degree KelvinN = Avogadros number = viscosity of mediumt = timer = radius of the particle

3.Electro kinetic Properties

Zeta Potential

The zeta potential is defined as the difference in potential between the surface of the tightly bound layer (shear plane) and electro-neutral region of the solution.

bAs the potential drops off rapidly at first, followed more gradual decrease as the distance from the surface increases.

This is because the counter ions close to the surface acts as a screen that reduce the electrostatic attraction between the

charged surface and those counter ions further away from the surface.

Zeta potential has practical application in stability of systems containing dispersed particles .

Since this potential, rather than the Nernst potential, governs the degree of repulsion between the adjacent, similarly charged, dispersed particles.

If the zeta potential is reduced below a certain value , the attractive forces exceed the repulsive forces, and the particles come together.

This phenomenon is known as flocculation.

The flocculated suspension is one in which zeta potential of particle is -20 to +20 mV.

Thus the phenomenon of flocculation and de flocculation depends on zeta potential carried by particles.

Deflocculation and flocculationFlocculated Suspensions In flocculated suspension, formed flocs (loose aggregates) will cause increase in sedimentation rate due to increase in size of sedimenting particles.

Hence, flocculated suspensions sediment more rapidly.

Here, the sedimentation depends not only on the size of the flocs but also on the porosity of flocs.

Deflocculated suspensions

In deflocculated suspension, individual particles are settling.

Rate of sedimentation is slow , which prevents entrapping of liquid medium which makes it difficult to re-disperse by agitation.

This phenomenon called caking or claying.

In deflocculated suspension larger particles settle fast and smaller remain in supernatant liquid so supernatant appears cloudy.

The formulation of a suspension depends on whether the suspension is flocculated or deflocculated.

Three approaches are commonly involved

1. Use of structured vehicle 2. Use of controlled flocculation3. Combination of both of the methods

:FORMULATION OF SUSPENSIONS

Flow chart of formulation of suspension

Structured vehicles called also thickening or suspending agents.

They are aqueous solutions of natural and synthetic gums.

These are used to increase the viscosity of the suspension.

It is applicable only to deflocculated suspensions.E.g. methyl cellulose, sodium carboxy methyl cellulose,

acacia, gelatin and tragacanth.

Structured vehicle

These structured vehicles entrapped the particle andreduces the sedimentation of particles.

Thus, the use of deflocculated particles in a structure vehicle may form solid hard cake upon long storage.

Too high viscosity is not desirable as:

a) It causes difficulty in pouring and administration.

b) It may affect drug absorption since they adsorb on the surface of particle and suppress the dissolution rate.

Structured vehicle is not useful for Parenteral suspension because they may create problem in syringeability due to high viscosity.

Controlled flocculation of particles is obtained by adding flocculating agents, which are:

(1) electrolytes

(2) surfactants

(3) polymers

Controlled flocculation

Sometimes suspending agents can be added to flocculated suspension to retard sedimentation

Examples of these agents are:

Carboxymethylcellulose (CMC), Carbopol 934, Veegum, and bentonite

Flocculation in structured vehicles

FORMULATION OF SUSPENSIONS

INGREDIENTS FOR

.Wetting agents They are added to disperse solids in continuous liquid phase.

Flocculatingagents

They are added to floc the drug particles

Thickeners They are added to increase the viscosity of suspension.

Buffersand pH adjusting agents

They are added to stabilize the suspension to a desired pH range.

Osmoticagents

They are added to adjust osmotic pressure comparable to biological fluid.

Coloringagents

They are added to impart desired color to suspension and improve elegance.

Preservatives They are added to prevent microbial growth.

Externalliquid vehicle

They are added to construct structure of the final suspension.

Suspending agent are also known as hydrophilic colloids which form colloidal dispersion with Water and increase the viscosity of the continous phase.

Suspending agent form film around particle and decrease interparticle attraction.

Most suspending agents perform two functions

i.e. besides acting as a suspending agent they also imparts viscosity to the solution.

Suspending agents

Preferred suspending agents are those that give thixotropy to the media such as

Xanthan gum, Carageenan, Na CMC/MC mixers,Avicel RC 591 Avicel RC 581 andAvicel CL 611.

.

Suspending agents Stability pH range

Concentrations used as suspendingagent

Sodium alginate 4-10 1 5 %Methylcellulose 3-11 1 2 %Hydroxyethyl cellulose 2-12 1-2%Hydroxypropyl cellulose 6-8 1-2%Hydroxypropyl methylcellulose

3-11 1-2%

CMC 7-9 1-2%

Colloidalsilicon dioxide

0-7.5 2- 4 %

Stability pH range and concentrations of most commonly used suspending agents.

List of Suspending AgentsAlginatesMethylcelluloseHydroxyethylcelluloseCarboxymethylcelluloseSodium CarboxymethylcelluloseMicrocrystalline celluloseAcaciaTragacanthXantham gumBentoniteCarbomerCarrageenPowdered celluloseGelatin

Alginates

Alginate salts have about same suspending action to that of Tragacanth.

Alginate solution looses its viscosity when heated above 60C. due to polymerization.

Alginate granules

Maximum viscosity is observed at a pH range of 5-9 of alginate.

Chemically alginates are polymers composed of mannuronicacid and glucuronic acid monomers.

In practice, alginate is used at concentration less than 10 % w/w, particularly at 5 % w/w.

Methylcellulose

Methylcellulose is available in several viscosity grades.

The difference in viscosity is due to difference in methylation and polymer chain length.

Methylcellulose is more soluble in cold water than hot water.

Methylcellulose is stable at pH range of 3-11.

Methyl cellulosepowder

Methyl cellulose onheating

Gel form oncooling

Solution form

Hydroxy ethylcellulose:

Hydroxyethylcellulose (HEC) is another good suspending agent having somewhat similar characteristicsto methylcellulose.

In HEC hydroxyethyl group is attached to cellulose chain.

Unlike methylcellulose, HEC is soluble in both hot and cold water and do not form gel on heating.

Carboxy methylcellulose (CMC)

Carboxy methylcellulose is available at different viscosity grades.

Low, medium and high viscosity grades are commercially available.

In case of HV-CMC, the viscosity significantly decreases when temperature rises to 40 C from 25 C.

Therefore, to improve viscosity and stability of suspension MV-CMC is widely accepted.

Microcrystalline Cellulose (MCC; Tradename-Avicel)

It is not soluble in water, but it readily disperses in water to give thixotropic gels.

It is used in combination with Na-CMC, MC or HPMC, because they facilitate dispersion of MCC.

The advantages of MCC:

Alginate complex compositions are that they provide excellent stability.

Formulation of dry powder suspensions with MCC;

Alginate complexes produce an excellent dry readily hydratable and dispersible formulation for reconstitution.

Hydrophilic materials are easily wetted by water while hydrophobic materials are not.

However hydrophobic materials are easily wetted by non-polar liquids.

The extent of wetting by water is dependent on the hydrophillicity of the materials.

If the material is more hydrophilic less difficulty in wetting by water.

The concentration used is less than 0.5 %.

Wetting Agents

. Surfactants decrease the interfacial tension between drug particles and liquid thus liquid is penetrated in the pores of drug particle displacing air from them and thus ensures wetting.

Generally, we use non-ionic surfactants but ionic surfactants can also be used depending upon certain conditions.

Polysorbate 80 is most widely used due to its following advantages

It is non-ionic so no change in pH of medium No toxicity. Safe for internal use.

Surfactants

Hydrophilic colloids coat hydrophobic drug particlesin one or more than one layer.

This will provide hydrophillicity to drug particles and facilitate wetting.

They cause deflocculation of suspension because force of attraction is declined. e.g. acacia, tragacanth, alginates, guar

gum.

Hydrophilic Colloids

The most commonly used solvents used are alcohol,glycerin, polyethylene glycol and polypropylene glycol.

The mechanism by which they provide wetting is that they are miscible with water and reduce liquid air interfacial tension.

Liquid penetrates in individual particle and facilitates wetting.

Solvents

n.

Buffers are the materials which when dissolved in asolvent will resist any change in pH when an acid or base is added.

To encounter stability problems all liquid formulation should be formulated to an optimum pH.

Rheology, viscosity and other property are also dependent on the pH of the system.

Buffers

. Generally pH of suspension preferably at 7.4-8.4.

Most commonly used buffers are salts of weak acids such as carbonates, citrates,gluconates, phosphate and tartrates.

They are added to produce osmotic pressure comparable to biological fluids when suspension is to be intended for

ophthalmic or injectable preparation.

Most commonly used osmotic agents are

dextrose, mannitol sorbitol. sodium chloride, sodium sulfate glycerol.

Osmotic Agents

Naturally occurring suspending agents such as tragacanth, acacia, xanthan gum are susceptible to microbial contamination.

This leads to:

loss in suspending activity of suspending agents, loss of color, flavor and odor, change in elegance etc.

Preservatives

Name of preservatives Concentration range

Propylene glycol 5-10%Disodium EDTA 0.1%Benzalkonium chloride 0.01-0.02%Benzoic acid 0.1%Butyl paraben 0.006-0.05% oral

suspension0.02-0.4% topical formulation

Disodium EDTA benzalkanonium

They are added to increase patient acceptance.

Only sweetening agent are not capable of complete taste masking of unpleasant drugs therefore, a flavoring agents are incorporated.

Flavoring And Coloring Agents

Acacia Ginger Sarsaparilla syrup

Anise oil Glucose Spearmint oilBenzaldehyde Glycerin Thyme oil

Eg:

Colors are obtained from natural or synthetic sources.

Plant colors are most widely used for oral suspension.

The synthetic dyes should be used within range of( 0.0005 % to 0.001%)

Coloring agents

Color aids in identification of the product.

The color used should be acceptable by the particular country.

Most widely used colors are as follows.

Titanium dioxide (white)

Brilliant blue (blue)

Indigo carmine(blue)

Amaranth (red)

Tartarazine (yellow)Annatto seeds(yellow to orange)

Annatto seeds

They are used for taste masking of bitter drug particles.

Bulk sweeteners

Sugars such as xylose, ribose, glucose, mannose.

Sugar alcohols such as sorbitol, xylitol, mannitol

A bulk sweeteners is used at concentration of 15-70 %

Sweetening Agents

Artificial sweetening agents

Sodium cyclamate

Sodium saccharin

Aspartame

Humectants absorb moisture and prevent degradation of API by moisture.

Examples of humectants most commonly used insuspensions are

propylene glycol

glycerol.

Total quantity of humectants should be between 0-10 % w/w.

Humectants

Ascorbic acid derivatives such as ascorbic acid, erythorbic acid,

Thiol derivatives such as thio glycerol, cytosine, acetylcysteine,

Tocopherols

Butylated hydroxy anisole(BHA)

Butylated hydroxytoluene (BHT)

Sodium bi sulfite,

Sodium sulfateacetone

Antioxidant

Following consideration are important for manufacturing pharmacist

Selection of right material that go into the manufacture.

The step involved and their sequence in the manufacture.

Preservation and storage of the product.

PREPARATION OF SUSPENSIONS

Small scale preparation of suspensions:

Step 1:

Suspensions are prepared by grinding (or) levigating the insoluble

materials in the mortar to a smooth paste with a vehicle containing the

wetting agent.

Step 2:

All soluble ingredients are dissolved in same portion of the vehicle and added to the smooth paste to step1 to get slurry.

Step 3:

The slurry is transformed to a graduated cylinder, the mortar is rinsed with successive portion of the vehicle.

Step 4:Decide whether the solids are

Suspended in a structured vehicleFlocculatedFlocculated and then suspended

Add the vehicle containing the suspending agent (or) flocculating agent

Make up the dispersion to the final volume .

Thus suspension is prepared.

Step-5

Introduction

Pharmaceutical suspensions for oral use are generally packed in wide mouth container having adequate space above the liquid to ensure proper mixing.

Parenteral suspensions are packed in either glass ampoules or vials.

Packaging of Suspensions

Ideal Requirements of Packaging Material

It should be inert.

It should effectively preserve the product from light, air, and other contamination through shelf life.

It should be cheap.

It should effectively deliver the product without any difficulty.

Materials Used For Packaging

Generally glass and various grades of plastics are used in packaging of suspension.Glass

Generally soda lime and borosilicate glass are usedin preparation of non sterile suspensions.

Amber glass doesnt allow U.V light to pass through.

Amber characteristics can be developed in the glass by addition of various types of additives.

Type of glass Additive giving amber color

Soda lime FeO + sulfur (in presence of reducing agent)

Borosilicate FeO+TiO 2

Disadvantages of Glass Materials:

They are fragile.

They are very heavy as compared to plastic so handling and transport is difficult.

Most important disadvantage of glass thatglass constituents get extracted into the product.

Plastic

Due to the negative aspects of glass, plastic material significantly use of plastic as packaging material for sterile as well as non-sterile pharmaceutical suspension increased.

Advantages Of Plastic Material:

Non breakability.Light weight.Flexibility.

Materials used: -

Polyethylene, PVC, polystyrene, polycarbonate etc

Closure And Liners

With an exception of ampoules all containers requiredelastomeric closure.

.

closures

liners

Factors affecting in selecting closure:

Compatibility with product.

Seal integrity.

It should be stable throughout the shelf life.Factors affecting in selecting liner:

Chemical resistance.Appearance Gas and vapor transmission. Removal torque. Heat resistance. Shelf life. Economical factors

STORAGE REQUIREMENTS & LABELLING

Labelling:

Shake well before use

Do not freeze

Protect from direct light(for light sensitive drugs)

In case of dry suspensions powder the specified amount of vehicle to be mixed may indicated clearly on label.

Label:

STORAGE :

Suspensions should be stored in cool place but should not be kept in a refrigerator

Freezing at very low temperatures should be avoided which may lead to aggregation Of suspended particles

Stored at controlled temperature from 20-25 c0

Sedimentation method

Rheological method Electro kinetic method

Micromeritic method

Evaluation of Suspensions

Sedimentation method :

Two parameters are studied for determination of sedimentation.

1. Sedimentation volume,

2. Degree of flocculation.,

Sedimentation volume

The suspension formulation (50 mL) was poured separately into100 mL measuring cylinders and sedimentation volume was readafter 1, 2, 3 and 7 days, and thereafter at weekly intervals for 12 weeks.

Triplicate results were obtained for each formulation.

Sedimentation volume was calculated according to the equation:

Where, F = sedimentation volume, Vu = ultimate height of sedimentand Vo = initial height of total suspension

F = Vu/Vo

Rheological method

It provide information about Settling behaviour .

The arrangement of the vehicle and the particle structural features.

Brookfield viscometer is used to study the viscosity of the suspension . It is mounted on heli path stand and using T-bar spindle.

T-bar spindle is made to descend slowly into the suspension and the dial reading on the viscometer is then a measure of the resistance the spindle meets at various level.

This technique also indicates at which level of the suspension the structure is greater owing to particle agglomeration.

The dial reading is plotted against the number of turns of the spindle.

The better suspension show a lesser rate of increase of dial reading with spindle turns, i.e. the curve is horizontal for long period.

Electro kinetic method

Measurement of Zeta-potential using Micro electrophoresis apparatus & ZetaPlus (Brookhaven Instruments Corporation, USA)

It shows the stability of a disperse system.

Micro-Electrophoresis Apparatus Mk I

ZetaPlus

Zeta potential

The zeta potential of the formulated suspensions was determinedusing a ZetaPlus (Brookhaven Instruments Corporation, USA).

Approximately 1 mL of suspension was transferred into a plasticcuvette using a pipette and diluted with distilled water.

The Brookhaven zeta potential software was used for themeasurement .Parameters set to a temperature of 250C and refractive index (1.33)

The zeta potential of the formulations was determined on day 0, 7,14, 21 and day 28 post formulation.

Micromeritic method :

The stability of suspension depends on the particle size of the dispersed phase.

Change in the particle size with reference to time will provide useful information regarding the stability of a suspension.

A change in particle size distribution and crystal habit studied by

microscopy

coulter counter method

PHOTOMICROSCOPIC TECHNIQUE

The microscope can be used estimate and detect changes in particle size distribution and crystal form.

Rapid processing of photo micrographs is enhanced by attaching Polaroid camera to the piece of monomolecular microscope

By using this photo micrographs we can determine the changes in physical properties and stability of suspensions.

Freeze-Thaw test conducted by placing the sample in a freezer for 18 hours followed by thawing at room temperature for 4 to 6 hours.

Repeat the Freeze-Thaw cycle for up to 10 times.

FREEZE- THAW TEST

Freeze-thaw testing freezer INNER CHAMBER

This test is conducted to determine the tendency to crystallize or cloud

pH MEASUREMENT

The measurement and maintenance pH is also very important step in the Quality control testing .

Generally there are 2 different types of methods used in the measurement of pH.

METHODS FOR pH MEASUREMENT:

The simplest and cheapest is to dip a piece of pH paper into the sample.

The paper is impregnated with chemicals that change color and the color may be compared to a chart supplied with the paper to give the pH of the sample.

If greater accuracy is required a pH meter should be used.

A typical pH meter consists of a special measuring glass electrode connected to an electronic meter that measures and displays the pH reading.

VISUAL INSPECTION:

With visual inspection, the ingredients and the final products are carefully examined for purity and for appearance .

Physical appearance of products for patient adherence and compliance is critical so it should be:

Good looking Elegance in appearance .

DISSOLUTION STUDY OF SUSPENSIONS

Introduction:

The drug release from suspensions is mainly through dissolution.

Suspensions share many physico-chemical characteristics of tablet & capsules with respect to the process of dissolution.

As tablets & capsules disintegrate into powder and form suspensions in the biological fluids.

So dissolution is carried as follows

Dissolution Testing

Official Method (Conventional Method):

It is known as paddle method.

Dissolution profile of the 500 mg sample suspension is

determined at 37C in 900 ml of

pH 7.2 phosphate buffer using

the FDA paddle method at 25 RPM.

The apparatus consists of a cylindrical 1000- ml round bottom flask in a multiple spindle dissolution drive apparatus and immersed in a controlled temp bath maintained

The paddle should position to extend to exactly 2.5 cm above the flask bottom.

The suspension is to be introduced carefully into the flask at the bottom using a 10- ml glass syringe with an attachment 19-cm needle.

Withdraw 5 ml of dissolution medium (and replace with an equal volume of drug free buffer) in a 5 ml glass

syringe.

Immediately filter through a 0.2 m membrane and analyze.

INNOVATIONS OF SUSPENSIONS

1. Nano suspensions

2. Taste masked pharmaceutical suspensions

3. Sustained release suspensions

Nano suspensions are the biphasic colloidal dispersions of nano sized drug particles stabilised by surfactants without the matrix materials.

They can also be defined as a biphasic system consisting of pure drug particles dispersed in an aqueous vehicle in which the diameter of the suspended particle is less than 1 m in size.

1. Nano suspensions:

Un-palatability due to bad taste is a major concernin most of the dosage forms containing bitter drugs.

In case of suspensions also taste masking is being applied to mask bitterness of drugs formulated.

2.Taste Masked Pharmaceutical Suspensions .

The taste masking approaches for suspensions are:

a. Polymer coating of drugs.

b. Encapsulation with basic drugs.

c. Polymer coating with basic substances.

d. Coating and pH control.

a. Polymer Coating of Drugs

The polymer coat allows the time for all of the particles to be swallowed before the threshold concentration is reached in the mouth and the taste is perceived.

The polymers used for coating are

Ethyl celluloseEudragit RS 100Eudragit RL 100Eudragit RS 30 DEudragit RL 30 D

b. Encapsulation with a Basic Substance

Here a basic substance is mixed with a bitter tasting drug which is insoluble at high pH.

The mixer is then encapsulated with a polymer (cellulose derivative, vinyl derivative or an acid soluble polymer Eg: copolymer of dimethyl ammonium methyl methacrylate).

The drug after encapsulation are suspended, dispersed or emulsified in suspending medium to give the final dosage form.

c. Coating and pH Control

Those drugs which are soluble at high pH are preferably be maintained in a suspension at a low pH where the drug exhibit maximum insolubility.

Similarly drugs which are soluble at low pH are preferably maintained in suspension at a high pH where the drug is insoluble.

Also applying polymeric coating to the drug substance avoids solubilization of drug when administered providing taste masking.

Some Examples of Taste Masked SuspensionsSr.No Name of the drug Taste masking approach

1 RISPERIDONE pHcontrol and polymer coating (with Eudragit RS)

2 DICLOFENAC Polymercoating with Eudragit RS 100

3 LEVOFLOXACIN Polymercoating (Eudragit&cellulose acetate,)

Sustained release is a method to increase only the duration of action of drug being formulated without affecting onset of action.

In suspension sustained release affected by coating the drug to be formulated as suspension by insoluble polymer coating.

The polymer coating provides sustained release and also masks the taste of the bitter drug.

Sustained Release Suspensions

The polymer used for sustained release in suspension is as follows as

Ethyl cellulose, Eudragit, Cellulose acetate, etc.

The main advantage of sustained release suspension is decrease in dosing frequency.

Approaches used in formulation of sustained release oral suspensions

1. Ion exchange resin.

2. Microencapsulation technique

3. Saturated drug suspension as a suspending medium.

4. Using non aqueous vehicle.

5. Reconstitution.

6. Protective coating.

Subramanyam C.V.S., Second edition, Suspensions Text Book of Physical Pharamaceutics, PageNo. 374-387.

Ansel C., Allen L.V., Popovich N.G. Eighth edition Disperse systems Pharmaceutical Dosage Forms & Drug Delivery Systems, Lippincott Williams and Wilkins, Philadelphia 2005, Page No. Page No. 387-389, 398.

REFERENCES

Cooper & Gun, Sixth edition, Dispersed system Tutorial Pharmacy, Page No. 75-78.

Aulton M.E. Second edition, Suspension Pharmaceutics-The Science of Dosage Form Design, Churchill Livingstone, Edinburgh 2002, PageNo. 84-86, 273.

Remington, Twentieth edition, Colloidal Dispersions The Science and Practice of Pharmacy, Lippincott Williams and Wilkins, Philadelphia 2000, Page No. 298-307.

Martin A. Fourth edition, Coarse dispersion Physical Pharmacy, Lippincott Williams and Wilkins, Philadelphia 2001, Page No. 479-481.

Heartly thanks to

Prof .Dr. M.B.Venkatapathi Raju Sir,Principal,SRCP.Prof : G.Sudhakar sir , Vice principal,SRCP.Prof .Dr. R. Santosh Kumar sir , H.O.D,SRCP.

My Teachers and other faculty members and non teaching staff,SRCP.

Finally special thanks to Srinivasa Rao College of Pharmacy Management.

SUSPENSIONSSlide Number 2Slide Number 3Slide Number 4Slide Number 5Slide Number 6Slide Number 7Slide Number 8Slide Number 9Slide Number 10Slide Number 11Slide Number 12Slide Number 13Slide Number 14Slide Number 15Slide Number 16Slide Number 17Slide Number 18Slide Number 19Slide Number 20Slide Number 21Slide Number 22Slide Number 23Slide Number 24Slide Number 25Slide Number 26Slide Number 27Slide Number 28Slide Number 29Slide Number 30Slide Number 31Slide Number 32Slide Number 33Slide Number 34Slide Number 35Slide Number 36Slide Number 37Slide Number 38Slide Number 39Slide Number 40Slide Number 41Slide Number 42Slide Number 43Slide Number 44Slide Number 45Slide Number 46Slide Number 47Slide Number 48Slide Number 49Slide Number 50Slide Number 51Slide Number 52Slide Number 53Slide Number 54Slide Number 55Slide Number 56Slide Number 57Slide Number 58Slide Number 59Slide Number 60Slide Number 61Slide Number 62Slide Number 63Slide Number 64Slide Number 65Slide Number 66Slide Number 67Slide Number 68Slide Number 69Slide Number 70Slide Number 71Slide Number 72Slide Number 73Slide Number 74Slide Number 75Slide Number 76Slide Number 77Slide Number 78Slide Number 79Slide Number 80Slide Number 81Slide Number 82Slide Number 83Slide Number 84Slide Number 85Slide Number 86Slide Number 87Slide Number 88Slide Number 89Slide Number 90Slide Number 91Slide Number 92Slide Number 93Slide Number 94Slide Number 95Slide Number 96Slide Number 97Slide Number 98Slide Number 99Slide Number 100Slide Number 101Slide Number 102Slide Number 103Slide Number 104Slide Number 105Slide Number 106Slide Number 107Slide Number 108Slide Number 109Slide Number 110Slide Number 111Slide Number 112Slide Number 113Slide Number 114Slide Number 115Slide Number 116Slide Number 117Slide Number 118Slide Number 119Slide Number 120Slide Number 121Slide Number 122Slide Number 123Slide Number 124Slide Number 125Slide Number 126Slide Number 127Slide Number 128Slide Number 129Slide Number 130